1. Liu, Yi-Ying, Wan, Qin. . Relationship between GCKR gene rs780094 polymorphism and type 2 diabetes with albuminuria. In World journal of diabetes, 14, 1803-1812. doi:10.4239/wjd.v14.i12.1803. https://pubmed.ncbi.nlm.nih.gov/38222779/
2. Zhu, Manning, Lv, Yaer, Peng, Yanqing, Tian, Jiawei, Sun, Litao. 2023. GCKR and ADIPOQ gene polymorphisms in women with gestational diabetes mellitus. In Acta diabetologica, 60, 1709-1718. doi:10.1007/s00592-023-02165-1. https://pubmed.ncbi.nlm.nih.gov/37524927/
3. Li, Jiaying, Zhao, Yuening, Zhang, Hongxiang, Yang, Xiaoqin, Zhu, Liyan. . Contribution of Rs780094 and Rs1260326 Polymorphisms in GCKR Gene to Non-alcoholic Fatty Liver Disease: A Meta-Analysis Involving 26,552 Participants. In Endocrine, metabolic & immune disorders drug targets, 21, 1696-1708. doi:10.2174/1871530320999201126202706. https://pubmed.ncbi.nlm.nih.gov/33243135/
4. Kimura, Masaki, Iguchi, Takuma, Iwasawa, Kentaro, Hwa, Vivian, Takebe, Takanori. 2022. En masse organoid phenotyping informs metabolic-associated genetic susceptibility to NASH. In Cell, 185, 4216-4232.e16. doi:10.1016/j.cell.2022.09.031. https://pubmed.ncbi.nlm.nih.gov/36240780/
5. Fernandes Silva, Lilian, Vangipurapu, Jagadish, Kuulasmaa, Teemu, Laakso, Markku. 2019. An intronic variant in the GCKR gene is associated with multiple lipids. In Scientific reports, 9, 10240. doi:10.1038/s41598-019-46750-3. https://pubmed.ncbi.nlm.nih.gov/31308433/
6. Si, Shucheng, Liu, Hongyan, Xu, Lu, Zhan, Siyan. 2024. Identification of novel therapeutic targets for chronic kidney disease and kidney function by integrating multi-omics proteome with transcriptome. In Genome medicine, 16, 84. doi:10.1186/s13073-024-01356-x. https://pubmed.ncbi.nlm.nih.gov/38898508/